Guggenhime Andrewinsider trades

In SEC Form 4 filings, Guggenhime Andrew is listed as PRESIDENT AND CFO of Vaxcyte, Inc. (PCVX). Guggenhime Andrew reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 9.

Companies and roles

Company	Role	Transactions	Last filed
PCVXVaxcyte, Inc.	PRESIDENT AND CFO	3	Sep 9

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
PCVXVaxcyte, Inc.	Sep 8	Sep 9	F	7,155	$60.36	$431,876	95,316	No	Form 4
PCVXVaxcyte, Inc.	Sep 2	Sep 2	F	1,432	$61.58	$88,183	102,471	No	Form 4
PCVXVaxcyte, Inc.	Aug 31	Sep 2	F	1,273	$60.74	$77,322	103,903	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.